Supporting respiratory epithelia and lowering inflammation to effectively treat common cold symptoms: A randomized controlled trial.

ABSTRACT: Common cold viruses are leading triggers of asthma attacks, causing nearly two million hospitalizations per year and productivity losses approaching $40B. They also increase susceptibility to bacterial infections driving antibiotic use. Post-market clinical studies have questioned the efficacy of most over the counter (OTC) cough and cold ingredients against placebo in treating various symptoms. To our knowledge, only aspirin significantly improved overall illness severity compared to placebo and that was by about 25-30%. In this double-blind randomized placebo-controlled trial involving 157 participants, we sought to determine whether a throat spray containing a mucosal immune complex (MIC) (comprised of lysozyme, lactoferrin, and aloe) along with anti-inflammatory salicylates can increas

SUBMITTER: Pugach P 

PROVIDER: S-EPMC11602100 | biostudies-literature | 2024

REPOSITORIES: biostudies-literature